Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage.


The enzymatic processes underlying the degradation of aggrecan in cartilage and the corresponding changes in the biomechanical properties of the tissue are an important part of the pathophysiology of osteoarthritis. Recent studies have demonstrated that the hexosamines glucosamine (GlcN) and mannosamine (ManN) can inhibit aggrecanase-mediated cleavage of… (More)


  • Presentations referencing similar topics